Dr. Cathcart is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Memorial Sloan Kettering Cancer Center New York
1275 York Avenue
New York, NY 10021
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1995 - 1998
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1992 - 1995
- Rutgers New Jersey Medical SchoolClass of 1992
Certifications & Licensure
- NJ State Medical License 2004 - 2025
- NY State Medical License 1994 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia Start of enrollment: 1999 Mar 01
Publications & Presentations
PubMed
- 154 citationsA multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia.Kathleen Cathcart, Javier Pinilla-Ibarz, Tatyana Korontsvit, Joseph J. Schwartz, Victoriya Zakhaleva
Blood. 2004-02-01 - 197 citationsVaccination of patients with chronic myelogenous leukemia with bcr-abl oncogene breakpoint fusion peptides generates specific immune responsesJavier Pinilla-Ibarz, Kathleen Cathcart, Tatyana Korontsvit, Steven L. Soignet, Monica Bocchia
Blood. 2000-03-01 - 64 citationsGlutathione monoethyl ester can selectively protect liver from high dose BCNU or cyclophosphamide.Beverly A. Teicher, James M. Crawford, Sylvia A. Holden, Yawares J. Lin, Kathleen N. S. Cathcart
Cancer. 1988-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: